COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,225 Articles (22,733 medRxiv, 8,492 bioRxiv)

Most recent first Previous |  Page 158: Articles 1571-1580  | Next

Application and Significance of SIRVB Model in Analyzing COVID-19 Dynamics
Ariyaratne, P., Ramasinghe, L. P., Ayyash, J. S., Kelley, T. M., Plant-Collins, T. A., Shinkle, L. W., Zuercher, A. M., Chen, J.
10.1101/2024.09.21.24314129 — Posted: 2024-09-23
Postpartum Depression During the COVID-19 Pandemic and Associated Factors: A Cross-Sectional Study
Teruya, M. M., Carrijo, G. S., Costa, G. A. M., Da Silva, M. H., Lima, J. R. T. d., Costa, J. F. S. V., Strufaldi, R., Valete, C. O. S.
10.1101/2024.09.22.24314126 — Posted: 2024-09-23
Preventive interventions for post Covid-19 condition: systematic review update
Pillay, J., Rahman, S., Gehring, N., Guitard, S., Ashiq, A. R., Hartling, L.
10.1101/2024.09.18.24313918 — Posted: 2024-09-23
Emergence to dominance: Estimating time to dominance of SARS-CoV-2 variants using nonlinear statistical models
Awasthi, S., Zolfaghari Dehkharghani, M., Fudolig, M.
10.1101/2024.09.21.24314137 — Posted: 2024-09-23
Accurate Multiple Sequence Alignment of Ultramassive Genome Sets
Lai, X., Luan, H., Tian, P.
10.1101/2024.09.22.613454 — Posted: 2024-09-23
Neuroinvasive and neurovirulent potential of SARS-CoV-2 in the acute and post-acute phase of intranasally inoculated ferrets
Benavides, F. F. W., Kroeze, E. J. B. V., Leijten, L. M., Schmitz, K. S., van Run, P., Kuiken, T., de Vries, R. D., Bauer, L., van Riel, D.
10.1101/2024.09.21.614276 — Posted: 2024-09-23
Machine Learning Driven Simulations of SARS-CoV-2 Fitness Landscape
Durumeric, A. E. P., Koehler, J., Elez, K., Raich, L., Suriana, P. A., Sztain, T.
10.1101/2024.09.20.614179 — Posted: 2024-09-23
Tracing SARS-CoV-2 Clusters Across Local-scales Using Genomic Data
Lyu, L., Stott, G., Dailey, C., Subedi, S., Fujimoto, K., Penn, R., Brown, P., Sealy, R., Bahl, J.
10.1101/2024.09.18.24313896 — Posted: 2024-09-22
Wastewater surveillance overcomes socio-economic limitations of laboratory-based surveillance when monitoring disease transmission: the South African experience during the COVID-19 pandemic
Maree, G., Els, F., Naidoo, Y., Naidoo, L., Mahamuza, P., Macheke, M., Ndlovu, N., Rachida, S., Maposa, S., Taukobong, S., Iwu-Jaja, C., O'Reilly, K., Yousif, M., McCarthy, K.
10.1101/2024.09.20.24314039 — Posted: 2024-09-22
Assessing COVID-19 infection probabilities in response to alternate vaccine boosting frequencies for multiple-sclerosis patients undergoing disease-modifying therapy with beta-interferon, dimethyl fumarate, natalizumab, or teriflunomide
Dornburg, A., Hassler, H. B., Townsend, J. P.
10.1101/2024.09.19.24313891 — Posted: 2024-09-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).